16s rRNA Sequencing - 16s rRNA Sequencing

The global rare disease genetic testing market size is expected to reach USD 1.8 Billion by 2027 according to a new study by Polaris Market Research.

The report “Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Neurological Disorders, Immunological Disorders, Hematology Ailments, Endocrine & Metabolism Disorders, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders, Dermatology Disorders, Others); By Technology; By Specialty; By End-Use; By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Moreover, government-sponsored schemes are also expected to positively impact the market.

In February 2020, the government of India announced financial assistance of INR 15 lacs to the patients suffering from uncommon ailments under the Rashtriya Arogaya Nidhi scheme for a one-time treatment.

In terms of disease type, the market is segmented into neurological disorders, immunological disorders, hematology illnesses, endocrine & metabolism ailments, cancer, musculoskeletal disorders, cardiovascular disorders, dermatology illnesses, and others.

Based on technology, the rare disease genetic testing industry is further bifurcated into next-generation sequencing, array technology, PCR-based testing, FISH, sanger sequencing, and karyotyping.

The Protein Sequencing Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.

This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The report also covers detailed competitive landscape including company profiles of key players operating in the global market.

The key players in the protein sequencing market include Agilent Technologies, Inc., Bioinformatics Solutions, Charles River Laboratories, Proteome Factory, Rapid Novor Inc., Selvita, SGS, Shimadzu Corporation, Thermo Fisher Scientific Inc. and Waters.

An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.Get more information on "Global Protein Sequencing Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/protein-sequencing-market/download-sampleMarket DynamicsThe market is growing at a remarkable pace on account of increasing interest for development of target-based drugs.

The advent of technologies for de novo protein sequencing, advancement in technologies & rising spending by government to promote the research activities are some of the prominent factors fueling the market growth.

However, high cost of infrastructure & equipment is likely to curb the market growth.This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis.